Lifeward Ltd. LFWD 深 沪
交易中 05-18 12:12:04 美东时间
6.59
-0.110
-1.64%
华盛通- 最 高6.84
- 今 开6.84
- 成交量 3161股
- 最 低 6.50
- 昨 收 6.70
- 总市值 2494.12万
- 52周最高 15.24
- 市盈率 静 --
- 换手率 0.08%
- 52周最低 4.20
- 委 比 -25.00%
- 总股本 378.47万
- 历史最高 91782.60
- 量 比 1.11
- 振 幅 5.07%
- 历史最低 4.20
- 每 手 1
- 风险率 2.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lifeward Delays Quarterly Report Amid Deal Accounting
Lifeward ( ($LFWD) ) has released a notification of late filing. Lifeward Ltd. ...
05-15 22:17
Lifeward Q1 2026 Earnings Call Transcript
Lifeward (NASDAQ:LFWD) reported first-quarter financial results on Friday. The ...
05-15 21:10
Earnings Scheduled For May 15, 2026
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to...
05-15 19:11
Lifeward to Report First Quarter 2026 Financial Results on May 15, 2026
Lifeward Ltd. announced it will report its Q1 2026 financial results before U.S. markets open on May 15, 2026. A conference call and live webcast will follow at 8:30 a.m. EDT, hosted by Mark Grant, President and CEO, and Almog Adar, CFO. The call can be accessed via toll-free and international numbers, with an access code referencing the "Lifeward Earnings Call." A live webcast and archived version will be available on the Company’s website. Life...
05-11 13:25
Lifeward Restores Nasdaq Compliance With Audit Committee Changes
An update from Lifeward ( ($LFWD) ) is now available. Lifeward Ltd. had previou...
03-31 23:29
Lifeward Closes The Strategic Partnership Agreement With Oramed Pharmaceuticals
Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed
03-26 04:17
Lifeward Successfully Closes on Strategic Partnership with Oramed
Lifeward Ltd. announced the closure of its strategic partnership with Oramed Pharmaceuticals Inc., acquiring Oramed's POD™ technology and securing up to $47 million in capital, with $10 million accessed. The partnership aims to diversify Lifeward's biomedical portfolio and enhance profitability, supporting its mission to innovate for individuals with physical limitations.
03-25 20:10
Lifeward Faces Nasdaq Audit Committee Compliance Challenge
The latest announcement is out from Lifeward ( ($LFWD) ). On March 17, 2026, Li...
03-21 05:10
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
HC Wainwright & Co. Maintains Buy on Lifeward, Raises Price Target to $10
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Lifeward (NASDAQ:LFWD) with a Buy and raises the price target from $4.5 to $10.
03-19 20:25
